ESMO Targeted Anticancer Therapies Congress 2024

Start:

Mon, 26 Feb 2024, 09:00

End:

Wed, 28 Feb 2024, 17:00

Website:

https://iii.hm/esmotat24

Hashtag:

#ESMO2024

Venue:

Find ESMO On Social Media

Exhibit

Symposia

Workshops

Organiser

Sponsor

ESMO Targeted Anticancer Therapies Congress 2024, taking place from 26 to 28 February 2024 in Paris, France.

ESMO TAT offers participants a glimpse into the future of anticancer therapies, focusing on promising new targets and agents with a particular emphasis on early drug development.

Recognising the excellent opportunities that this event creates as a forum connecting key oncology stakeholders, ESMO TAT 2024 will underpin the vital collaboration required to improve the outcomes for cancer patients worldwide.

Speakers from both academia and industry will participate in an expanded programme, including four new joint ESMO-Industry special sessions addressing drug development, methodological, regulatory, strategic financing and investment issues, offering attendees a fresh, wide-ranging perspective on the development of innovative cancer therapeutics and their optimal implementation.

Empowering the views of stakeholders beyond academia, such as industry, investors and regulators will enrich the educational and scientific content of ESMO TAT 2024 in the fascinating arena of therapeutic innovation.

ESMO Targeted Anticancer Therapies Congress 2024: Registration

In-person participation includes:

Participation in the scientific and educational live sessions with the possibility to interact with the expert panel
Onsite networking opportunity with faculty and peers
Entry to the Poster area
Interaction with the Industry partners in the trade exhibition
Participation in the Industry Satellite Symposia
Access to the Post-event resources and sessions on-demand
Coffee breaks and lunches